Penglie Zhang
Inventor
Stats
- 52 US patents issued
- 164 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 52 US Patents Issued
- 164 US Applications Filed
- 1066 Total Citation Count
- Dec 3, 2024 Most Recent Filing
- May 24, 2000 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
MILLENNIUM PHARMACEUTICALS, INC. | 3
2 4 6 4 2 4 2 2 2 2 1 1 1 | 2000
2001 2002 2003 2004 2005 2006 2007 2010 2011 2012 2014 2015 2017 |
CHEMOCENTRYX, INC. | 3
4 9 4 6 10 7 2 4 13 4 8 10 3 | 2004
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 |
Wilco Marsh Buggies & Draglines, Inc. | 2
| 2002
|
Inventor Addresses
Address | Duration |
---|---|
Foster City, CA | Apr 23, 02 - Dec 04, 08 |
Foster City, CA, US | Jan 03, 02 - Mar 20, 25 |
San Francisco, CA | Mar 18, 03 - Oct 28, 03 |
South San Francisco, CA | Jan 18, 05 - Jan 18, 05 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 7 |
A61F: | FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 134 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0090,646 | 2025 | METHODS OF TREATING CANCER USING HETEROARYL-BIPHENYL AMIDE DERIVATIVES | 0 |
12139475 | 2024 | 2-oxindole compounds | 0 |
12054484 | 2024 | Substituted tetrahydropyrans as CCR2 modulators | 0 |
12018016 | 2024 | Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors | 0 |
12011439 | 2024 | Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.